๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of plasma levels for antiepileptic drug monitoring in clinical practice

โœ Scribed by ; E. Beghi; D. Trevisan; G. Tognoni; S. Arrigoni; G. Bogliun; L. G. Bongiovanni; S. Borgheresi; M. Benedetti; G. Beretta; A. Bianchi; U. Bocci; D. Buti; M. Buttiglione; G. Cagnin; C. Cardinali; G. Chiodelli; C. Ciampi; U. Colangelo; V. Crespi; C. A. Fanti; P. Ferri; D. Galeone; G. Giuliani; A. Neve; C. Lenti; V. Lepore; M. Lini; A. Ortenzi; T. Perniola; L. Piattella; D. Porazzi; A. Quattrini; M. R. Rottoli; R. Silvestri; L. M. Specchio; F. Spinogatti; V. Toso; M. Trizio; G. Zaccara; P. Zagnoni; N. Zamponi; P. Zolo


Publisher
Springer Milan
Year
1992
Tongue
English
Weight
495 KB
Volume
13
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Therapeutic advantages of monitoring pla
โœ Lars Bolvig Hansen; Niels-Erik Larsen ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 401 KB

Two hundred and twenty-eight acute paranoid psychotic in-patients received continuous treatment with perphenazine for a period of at least 5 weeks, before blood samples were taken to determine perphenazine plasma levels and conclusions regarding therapeutic efficacy and motor side effects. Patients